Revvity Basic Shares Outstanding 2010-2025 | RVTY
Revvity annual/quarterly basic shares outstanding history and growth rate from 2010 to 2025. Basic shares outstanding can be defined as the number of shares held by shareholders including insiders but not including a company's treasury shares.
- Revvity basic shares outstanding for the quarter ending March 31, 2025 were $0.120B, a 2.67% decline year-over-year.
- Revvity basic shares outstanding for the twelve months ending March 31, 2025 were $0.489B, a 1.67% decline year-over-year.
- Revvity annual basic shares outstanding for 2024 were $0.123B, a 1.56% decline from 2023.
- Revvity annual basic shares outstanding for 2023 were $0.125B, a 1.15% decline from 2022.
- Revvity annual basic shares outstanding for 2022 were $0.126B, a 8.6% increase from 2021.
| Revvity Annual Basic Shares Outstanding (Millions of US $) |
|
|---|---|
| 2024 | $123 |
| 2023 | $125 |
| 2022 | $126 |
| 2021 | $116 |
| 2020 | $112 |
| 2019 | $111 |
| 2018 | $111 |
| 2017 | $110 |
| 2016 | $109 |
| 2015 | $113 |
| 2014 | $113 |
| 2013 | $112 |
| 2012 | $114 |
| 2011 | $113 |
| 2010 | $117 |
| 2009 | $116 |
| Revvity Quarterly Basic Shares Outstanding (Millions of US $) |
|
|---|---|
| 2025-03-31 | $120 |
| 2024-12-31 | $123 |
| 2024-09-30 | $123 |
| 2024-06-30 | $123 |
| 2024-03-31 | $123 |
| 2023-12-31 | $125 |
| 2023-09-30 | $124 |
| 2023-06-30 | $125 |
| 2023-03-31 | $126 |
| 2022-12-31 | $126 |
| 2022-09-30 | $126 |
| 2022-06-30 | $126 |
| 2022-03-31 | $126 |
| 2021-12-31 | $116 |
| 2021-09-30 | $115 |
| 2021-06-30 | $112 |
| 2021-03-31 | $112 |
| 2020-12-31 | $112 |
| 2020-09-30 | $112 |
| 2020-06-30 | $111 |
| 2020-03-31 | $111 |
| 2019-12-31 | $111 |
| 2019-09-30 | $111 |
| 2019-06-30 | $111 |
| 2019-03-31 | $111 |
| 2018-12-31 | $111 |
| 2018-09-30 | $111 |
| 2018-06-30 | $110 |
| 2018-03-31 | $110 |
| 2017-12-31 | $110 |
| 2017-09-30 | $110 |
| 2017-06-30 | $110 |
| 2017-03-31 | $109 |
| 2016-12-31 | $109 |
| 2016-09-30 | $109 |
| 2016-06-30 | $109 |
| 2016-03-31 | $110 |
| 2015-12-31 | $113 |
| 2015-09-30 | $113 |
| 2015-06-30 | $113 |
| 2015-03-31 | $113 |
| 2014-12-31 | $113 |
| 2014-09-30 | $113 |
| 2014-06-30 | $113 |
| 2014-03-31 | $113 |
| 2013-12-31 | $112 |
| 2013-09-30 | $112 |
| 2013-06-30 | $112 |
| 2013-03-31 | $113 |
| 2012-12-31 | $114 |
| 2012-09-30 | $114 |
| 2012-06-30 | $114 |
| 2012-03-31 | $113 |
| 2011-12-31 | $113 |
| 2011-09-30 | $113 |
| 2011-06-30 | $112 |
| 2011-03-31 | $114 |
| 2010-12-31 | $117 |
| 2010-09-30 | $117 |
| 2010-06-30 | $117 |
| 2010-03-31 | $117 |
| 2009-12-31 | $116 |
| 2009-09-30 | $116 |
| 2009-06-30 | $116 |
| 2009-03-31 | $116 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $10.891B | $2.755B |
| Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $138.181B | 25.92 |
| Elevance Health (ELV) | United States | $85.871B | 11.08 |
| CVS Health (CVS) | United States | $80.417B | 10.00 |
| Cencora (COR) | United States | $56.019B | 19.49 |
| Natera (NTRA) | United States | $22.833B | 0.00 |
| DiDi Global (DIDIY) | China | $22.168B | 33.64 |
| BioMerieux (BMXMF) | France | $15.890B | 0.00 |
| Solventum (SOLV) | United States | $13.000B | 13.76 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.955B | 0.00 |
| CochLear (CHEOY) | Australia | $11.511B | 0.00 |
| ICON (ICLR) | Ireland | $11.274B | 10.48 |
| Doximity (DOCS) | United States | $10.250B | 47.45 |
| Viatris (VTRS) | United States | $10.082B | 3.46 |
| HealthEquity (HQY) | United States | $9.777B | 42.83 |
| Avantor (AVTR) | United States | $9.070B | 13.18 |
| Medpace Holdings (MEDP) | United States | $8.989B | 23.87 |
| Sonic Healthcare (SKHHY) | Australia | $8.365B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.034B | 13.78 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| BrightSpring Health Services (BTSG) | United States | $4.109B | 38.03 |
| Bausch + Lomb (BLCO) | Canada | $4.068B | 23.98 |
| Sotera Health (SHC) | United States | $3.508B | 19.93 |
| Alignment Healthcare (ALHC) | United States | $3.031B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.955B | 38.43 |
| Concentras Parent (CON) | United States | $2.766B | 15.98 |
| Organon (OGN) | United States | $2.477B | 2.63 |
| Ardent Health Partners (ARDT) | United States | $2.084B | 8.88 |
| GeneDx Holdings (WGS) | United States | $2.066B | 79.55 |
| Premier (PINC) | United States | $1.908B | 14.48 |
| Progyny (PGNY) | United States | $1.826B | 40.19 |
| PACS (PACS) | United States | $1.550B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.432B | 28.64 |
| Teladoc Health (TDOC) | United States | $1.249B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.194B | 9.09 |
| Establishment Labs Holdings (ESTA) | $1.075B | 0.00 | |
| CareDx (CDNA) | United States | $1.075B | 16.78 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.011B | 0.00 |
| Agilon Health (AGL) | United States | $0.907B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.768B | 7.19 |
| QDM (QDMI) | Hong Kong, SAR China | $0.755B | 0.00 |
| Nutex Health (NUTX) | United States | $0.753B | 11.41 |
| Embecta (EMBC) | United States | $0.608B | 4.09 |
| LifeMD (LFMD) | United States | $0.559B | 0.00 |
| Enhabit (EHAB) | United States | $0.538B | 44.25 |
| InnovAge Holding (INNV) | United States | $0.535B | 0.00 |
| SBC Medicals (SBC) | United States | $0.502B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.486B | 10.95 |
| Sonida Senior Living (SNDA) | United States | $0.460B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.423B | 0.00 |
| Oncology Institute (TOI) | United States | $0.286B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.240B | 0.00 |
| Beauty Health (SKIN) | United States | $0.210B | 0.00 |
| KindlyMD (KDLY) | United States | $0.150B | 0.00 |
| DocGo (DCGO) | United States | $0.147B | 24.00 |
| KindlyMD (NAKA) | United States | $0.103B | 0.00 |
| So-Young (SY) | China | $0.097B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.090B | 0.00 |
| OncoCyte (OCX) | United States | $0.084B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.073B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.064B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.046B | 0.00 |
| Biodesix (BDSX) | United States | $0.043B | 0.00 |
| ModivCare (MODV) | United States | $0.033B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |